Monte Rosa Therapeutics (GLUE) announced the company will present preclinical data on the potential of MRT-8102 at the American Heart ...
Results of the MRT-6160 Phase 1 SAD/MAD study demonstrate deep VAV1 degradation of greater than 90%, significant T and B cell functional inhibition as well as significant inhibition of cytokine ...
To assist commuters, 40 free shuttle buses are still in operation while MRT services continue to be closely monitored. Passengers are advised to refer to Rapid KL’s social media channels or the PULSE ...